New York, Jan 7, 2026, 12:41 EST — Regular session
- Robinhood shares were down about 2% in midday trading, tracking a softer tape for brokerage and crypto-linked stocks.
- A filing showed CEO Vladimir Tenev plans to sell up to 375,000 shares, worth about $43 million.
- Investors are looking ahead to Robinhood’s Feb. 10 quarterly results after a sharp 2025 run.
Robinhood Markets Inc (HOOD.O) shares fell 2.1% to $119.14 in midday trading on Wednesday after a filing showed Chief Executive Vladimir Tenev planned to sell up to 375,000 shares, worth about $43.2 million, through Morgan Stanley Smith Barney. The stock traded between $117.61 and $121.95.
The move matters because Robinhood has become a crowded trade after a strong run: its shares nearly tripled in 2025, Reuters Breakingviews reported, putting more weight on insider transactions and small shifts in expectations.
Form 144 is a notice insiders file ahead of a proposed sale of restricted or “control” stock. The filing referenced a Rule 10b5-1 plan, a pre-arranged trading plan that can schedule sales in advance.
Goldman Sachs analyst James Yaro lowered his price target on Robinhood to $161 from $164 and kept a buy rating, StreetInsider reported.
Crypto-linked and brokerage shares were broadly lower as bitcoin eased about 0.7% to $91,488. Coinbase fell 1.7%, while Interactive Brokers and Charles Schwab were also down in midday trade.
On the chart, traders have been watching the $117 area near the stock’s 200-day moving average, with the $125 zone near the 50-day average acting as a near-term hurdle, MarketBeat data showed. The same data put the average analyst price target at about $136.80.
Robinhood is due to report fourth-quarter and full-year 2025 results on Feb. 10 after the close, and it plans a video call with CEO Vlad Tenev and incoming CFO Shiv Verma at 5 p.m. ET. The company said its Q&A platform for shareholders opens Feb. 3.
But the business still swings with retail trading appetites, especially in crypto and options. A calmer market can sap transaction revenue, and any fresh regulatory heat around higher-risk products could hit sentiment quickly.
For now, investors will watch whether the stock holds above that longer-term support area and whether the proposed sales turn into actual selling. The next scheduled catalyst is the Feb. 10 earnings report.
